Deoxycholate is a bile salt. When this bile salt is injected into fat cells, it causes fat cell walls to rupture and release fatty acids. This bile salt binds to the free fatty acids to form micelles, which are water-soluble. They are transported via the blood to the liver. The mitochondria in the liver oxidize the free fatty acids to produce energy and the byproducts, water, and carbon dioxide (CO2). End products are transported to the intestines and excreted.

Deoxycholate has an active lipolytic effect and, when injected into fat cells on its own, may localise in certain areas, due to precipitation and cause a greater lipolytic effect in certain areas, compared to others. This can lead to vacuolisation – areas losing more fat cells than others – which can lead to irregularities.

When Phosphatidylcholine is combined with Deoxycholate, Phosphatidylcholine maintains Deoxycholate in solution and prevents precipitation. This ensures a distributed necrolytic effect of fat cells, with overlying collagen fibers remaining intact.

Research has also proven that a combination treatment involving Phosphatidylcholine and Deoxycholate leads to a marked reduction in inflammation with less swelling and discomfort.

The Phosphatidylcholine in the Liposolution formula is extracted only from high quality Soy-Lecithin. The concentration of Phosphatidylcholine is high and the ratio of Phosphatidylcholine to Deoxycholate ensures that the active Deoxycholate remains in solution to prevent precipitation and vacuolisation when injected. The product is manufactured and regularly tested to ensure that Lyso-PC-levels, (a by-product of the manufacturing process), are maintained at levels below 1%.

Obesity – a BMI above 26
Acute infections
Poorly regulated Diabetes mellitus
Heart, Kidney, or Liver disease or failure
Certain Auto-immune diseases – consult your medical practitioner
Anti-coagulation therapy (Blood-thinning medication)
Poorly perfused skin following surgery
Allergies to any ingredient of the injectable solution

Your medical practitioner will first provide you with comprehensive information about the active ingredient during a personal consultation. Injection-Lipolysis is recommended for people of normal weight with areas of stubborn fat pockets. It is not suitable for severely overweight patients and other measures should be considered.

During the treatment, the active substance is injected directly into fat pockets with fine needles. This active ingredient dissolves fat cells. The body transports the released fat to the lymphatic system and the liver. This is an amplification of natural processes that take place in the body every day.

The treatment is performed at your practitioner’s clinic. Depending on the treatment area, the treatment time is 30-45 minutes. Shortly after your Injection-Lipolysis session, you will notice a localised reaction in the form of redness and swelling. A burning sensation, moderate pain, and tenderness may be experienced. These symptoms subside after a few days. Your practitioner will advise you on pain relief measures.

As a result of the treatment, fat pockets are usually visibly reduced within 4-8 weeks, depending on the extent of fat in the treated area. On average, 2-4 sessions at intervals of 8 weeks are necessary to achieve optimal results. The average reduction in circumference varies between 3,5 and 5 cm, but may, in some cases, exceed this. More than 85% of patients are very satisfied with their results after 2-4 treatments.

Redness – on average, may last 48-72 hours
Bruising – on average, bruising lasts 5-7 days, but may last up to 10 days
Swelling – pronounced swelling of the treated area (-s) for 72 hours and moderate swelling for a further 24 hours (body) and 48 hours (face)
Discomfort – Discomfort may be pronounced for 48 -72 hours, followed by mild discomfort for a further 24-48 hours. Oral anti-inflammatory medication may relieve this discomfort
Tenderness – Treated areas normally remain tender to touch for 7 days, but this may continue for up to 14 days
Pain – Pain may be experienced for up to 72 hours, but in isolated cases, pain may persist for up to 7 days
Temporary circulatory insufficiency – This may be due to oedema and can lead to dizziness and collapse
Diarrhoea – Fatty stools may be difficult to flush. The higher the dose of PPC-DOC solution used, the higher the incidence of short-lived diarrhoea
Bleeding – Breakthrough bleeding in female patients, due to the release of Oestrogen, stored in fat